Red Light Holland Archives - Green Market Report

Adam JacksonJuly 26, 2022
mushroom.jpg?fit=960%2C640&ssl=1

5min7320

Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) will acquire two retail stores based in the Netherlands in a bid to expand their psychedelic truffles and wellness products.

 The company also said the acquisition makes Red Light Holland fully vertical – marrying their production, packaging and distribution operations with the retail shops and online sales. The company added that it will consider the creation of multiple Wellness World SmartShops across the Netherlands and Europe through acquisitions, franchising and/or constructing innovative stores in new locations.

Wellness Shops

 The shops – known as Smartshops OSS and Utrecht – will be rebranded as “Wellness Shops” in the fourth quarter of 2022. The price tag for the shops are 100,000 and 200,000 Euros, respectively. The deal is expected to close by Aug. 1.

 “I’ve been observing the SmartShop business for quite some time, and the industry really seems to be picking up as more and more people learn about psilocybin,” said Red Light Holland’s President Hans Derix. “What we are most elated by is our plan to rebrand with the focus on wellness products. We want to continue to end stigmas and help educate people to make informed decisions on the products they buy. The Netherlands, in my opinion, is definitely ready to see advanced, well-designed sharp looking Wellness World shops. And our team at SR-Wholesale is excited to supply the products to the new shops in two beautiful city centres: Oss and Utrecth with lots of tourism and tons of foot traffic.”

 The Ontario-based corporation engages in the production, growth, and sale of functional mushroom home grow kits in North America, and a premium brand of magic truffles to the legal, and recreational market within the Netherlands.

 The Wellness Shops will also sell CBD products, cannabis seeds, smart shop items, and other various popular wellness products. Additionally, they will carry only Red Light Holland’s Magic truffles products (iMicrodose, Maka and future brands) as Red Light Holland can curate the products sold by the retail locations. The Wellness Shops are profitable and have seen an increase in sales month over month during recent months, the release said.

In March, Green Market Report noted that the company reported its fiscal third quarter financial results with revenues of $622,247 for the quarter resulting in a gross profit of $232,792, an increase of $75,822 (or 48.3%) over the previously reported quarter. At that time, the company noted it was harvesting a batch of psilocybin mushrooms and that some of that was allocated for packaging and distribution within the Netherlands (under the iMicrodose” brand) and wholesale distribution.

 “We will be fully vertically integrated in the Netherlands, from substrate to sale, and that’s exciting as we look to increase sales around psychedelics responsibly,” said CEO Todd Shapiro.

 


Dave HodesJune 27, 2022
mushroom-3.jpg?fit=667%2C1000&ssl=1

10min15640

In Oregon, when voters approved Ballot Measure 109 calling for the legalization of psilocybin in November 2020, there was a silent hurrah throughout the state among people who took magic mushrooms for fun that went something like this: “Now we can go in to a psilocybin store and get a few grams of ‘shrooms—or maybe a handful—for the next concert.”

But that wasn’t the case. The measure was created to provide psilocybin for mental health therapy. It was strictly medicine. Wasn’t it?

Sometime early next year, if all goes according to plan, anyone over 21 will be able to go into a store in the state and buy magic mushrooms. But then they would have to sit through an “administration session” as a client of the facility, where they would consume and experience the effects of psilocybin under the supervision of a licensed psilocybin service facilitator. An “integration session” would follow where the client and a psilocybin service facilitator would discuss the experience.

It’s all pretty much just an extended doctor’s office visit, and brings into sharp focus what some believe to be the hollow victory of the state’s recreational psilocybin legalization: They are not for recreation at all.

Right now, the state is still in the process of setting up all the details of this psilocybin buying/selling/experiencing program. This includes: establishing rules by the end of the year; securing and customizing a product tracking system; creating an equity and justice centered approach to background checks; continuing to hire licensing and compliance teams; supporting the Oregon Psilocybin Advisory Board and subcommittees; creating education and training for their regulatory community and the public; and more.

But people looking for recreational fun with ‘shrooms don’t want to go to a medical clinic, or whatever these facilities will be morphing into as the regulations are developed and they begin operations. 

And outside of the concert or the dance club, people are beginning to use psilocybin as a smidgen of a bit of ‘shroom in their morning coffee, for example, to help set up a relaxing and productive day. That’s a trend that is catching on, rooted in Silicon Valley enterprises.

So the questions remain: Is legalized recreational psilocybin strictly medicine? Or can it also be a daily brain treat like some sort of advanced specialized brain health supplement? Or is it—will it become—a whole new recreational experience once people began tinkering with it outside of clinical studies and beyond the scope of any new regulations?

Not even the current Oregon state regulatory body can figure that out. Microdosing was not addressed, meaning that, even though recreational psilocybin is legal, microdosing is illegal right now. 

And there is confusion and debate around how medical Oregon’s psychedelics program will be structured. “I think there’s been a disconnect in what voters were told to expect when they voted and now. People will want mental health treatment but it’s not medical,” said Kimberley Golletz, a licensed psychologist and member of the Oregon Psilocybin Advisory Board giving guidance on the rules, as quoted in an article by Stat, a health and life sciences publication.

Real recreational legalization is part of the goal of Red Light Holland (OTC: TRUFF), an Ontario-based company that offers microdoses of magic truffles in their iMicrodose kit. A magic truffle is the fruiting body below the ground of the psilocybin mushroom. Magic truffles and magic mushrooms are both parts of the same organism that creates psilocybin, and have the same trippy effects after ingestion (though truffles’ effects are reportedly milder). Due to a loophole in Dutch law, magic truffles are legal but magic mushrooms are not. No therapists. No integration sessions. Just responsible adults going about their business buying magic truffles and enjoying their psilocybin experience.

Red Light Holland has been working on getting their products to other countries, such as Brazil and Canada, from their grow operations in The Netherlands. 

The company was created around the production, growth and sale of magic truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws. 

In an interview with The Street, an investment information company, Red Light Holland director and CEO Todd Shapiro said that he believes that magic truffles are a consumer goods product that is poised to cross more international borders. “We’re doing this because people are getting it anyway,” he said. “There are illicit markets anywhere you look. If people want to get access to this anyway, why not do it legally, why not do it carefully, and responsibly, and provide them that education that we are doing now. The careful use is the most important thing.”

So psilocybin is medical, but not… it’s illegal everywhere, except where it’s not… it’s turning into something like an uplifting food and beverage supplement to be combined with yoga or meditation, but that’s not really it either. It’s morphing, it’s evolving, it’s a moving target.

Perhaps the best thing that recreational psilocybin legalization has done is put more focus on achieving better brain health in general. According to results from an AARP survey, nearly one-quarter of adults age 18 and older currently take a supplement to maintain or improve brain health or delay or reverse dementia. That means that 58 million Americans (30 million age 50+) buy supplements believing it will help their brain health. Nine million adults age 50+ (8 percent) are taking a dietary supplement thinking it will actually reverse dementia.

Bottom line? There actually is no defined bottom line. But keep an eye on Oregon’s program, which could become the model of recreational psilocybin for other states as decriminalization continues—if all goes according to plan.


Debra BorchardtMarch 2, 2022
shutterstock_579231529-1-scaled.jpg?fit=1200%2C800&ssl=1

6min11490

Red Light Holland Corp. (CSE: TRIP) (OTC Pink: TRUFF)  reported its financial results for the fiscal third quarter ending December 31, 2021. Red Light said it generated revenues of $622,247 for the quarter resulting in a gross profit of $232,792, an increase of $75,822 (or 48.3%) over the previously reported quarter. All amounts are expressed in Canadian dollars.

“As a result of our team’s hard work and commitment, I am pleased to announce revenue and gross profit increased by 28% and 48%, respectively, during the third quarter. We realized growth in both the Netherlands and Canada through SR Wholesale and Happy Caps, as increased revenue remains our core focus. We are on-track with the strong foundation that we are building and we are excited about future revenue generation with AEM, which is now in early-stage production, current and future CPG expansion, and other potential strategic acquisitive opportunities,” said Todd Shapiro, Red Light Holland CEO and Director. “Our mission remains as well: to provide affordable and equitable naturally-occurring adult access via technology, education, information and responsible use. As you know, I love marketing and brand building – we will push even harder in the near future with impactful marketing strategies with the continued goal of Red Light Holland being the leader in the Rec and Tech psychedelic’s sector. We will provide updates shortly regarding Scarlette Lillie Science and Innovation (MERA) in St. Vincent, Wisdom Truffle pre-sales, and we continue to identify and analyze near term merger and acquisition transactions while remaining cautious with our spending habits. I’m very proud of our energetic and passionate Red Light Holland team as we keep delivering and putting the pieces of the puzzle together. I am grateful for our shareholders’ patience and continued support. Feel free to contact me anytime with the email provided below.”

Second Batch

In November 2020, Red Light began growing its second crop which was anticipated to yield 1,000,000 grams of the Psilocybe Mexicana, Psilocybe Galindoi, and Psilocybe Tampanensis strains of truffles (the “Second Batch”). The Second Batch became available for harvest in calendar Q2 2021. For clarity, once a batch is ready for harvest, the harvest does not immediately have to take place but rather can be done several months later. The company has allocated the Second Batch for packaging and distribution within the Netherlands (under the iMicrodose” brand) and wholesale distribution. As of the date of the filed MD&A, approximately 661,000 grams of the harvest have been sold. The company said it plans to continue selling truffles from the second batch throughout the calendar second quarter of 2022.

In January 2022, Red Light began a continuous production schedule of smaller batch sizes of approximately 100,000 grams (the “Continuous Batches”). This new production schedule allows for the increased flexibility of strain selection and production process to ensure that we meet customer demand and improve harvest yields to reduce production costs per gram.

Health Canada

In January 2022, Health Canada published amendments to its Special Access Program which now allows access to psychedelics such as psilocybin for patients in medical need on a case-by-case basis. This amendment will allow physicians to request access to psilocybin when other therapies have failed and where there is sufficient evidence of safety and efficacy for the treatment of the patient’s condition. Health Canada’s decision may offer patients who have not responded to existing therapies new avenues to receive care. Following Health Canada’s announcement, CCrest Laboratories Inc., our partner in psilocybin research, was approved by Health Canada to supply psilocybin under the Special Access Program.

Sarah Hashkes, Red Light Holland’s CTIO added, “With the recently published amendments to Health Canada’s Special Access Program which now allows physicians to request access to psilocybin for patients in medical need on a case-by-case basis, Red Light Holland is looking ahead to participating in this changing landscape. Our research has resulted in significant steps towards the standardization of determining the appropriate dosages required in emerging markets as a result of Health Canada’s Special Access Program and the state of Oregon’s Measure 109. We have also expanded our education and advocacy by partnering with Psychedelic Medicine Alliance Washington, a grassroots movement in the state of Washington.”

In January 2022, Red Light Oregon sent a report to the Oregon Health Authority and to the Oregon Advisory Board focused on microdosing research along with specific recommendations for microdosing within Oregon’s Measure 109.

With regards to the strength of the current balance sheet, David Ascott, Red Light Holland Chief Financial Officer, added “Our financial position remains strong, and the Company currently has sufficient capital to fund its ongoing business development and future growth and expansion plans for the foreseeable future. The working capital as of December 31, 2021, is $27.1 million which includes $27.3 million of cash and cash equivalents.”


StaffAugust 30, 2021
psychedelic.jpg?fit=960%2C640&ssl=1

3min16060

Psychedelic companies Red Light Holland Corp. (CSE: TRIP) (OTC Pink: TRUFF) and Creso Pharma Limited (ASX: CPH) (OTCQB: COPHF)  have mutually agreed to terminate the previously announced plan to merge. The two companies had announced in June they would combine, but now cite various impacts from the COVID-19 pandemic, including significant travel restrictions, where they decided that the merger would no longer be in the best interests of their respective shareholders.

“While we determined that a merger was no longer in the best interests of the two companies, we look forward to continuing to work closely with Adam Blumenthal and the rest of the Creso Pharma team as Red Light Holland has agreed to white-label Creso Pharma’s products and distribute them across our SR-Wholesale sales channels,” said Todd Shapiro, CEO and Director of Red Light Holland. “We are also continuing our search for other M&A opportunities as we are confident that our large cash balance puts us in a position of strength as potential progressive regulatory changes in the North American psychedelic and recreational cannabis sectors open up.” Red Light Holland did not that Bruce Linton, the founder and former chief executive officer of Canopy Growth Corporation, will remain as a Chairman of Red Light Holland’s Advisory Board.

As the two companies have significant operations in multiple countries across the globe, the two said that it became increasingly apparent that integration difficulties would limit the anticipated synergies from the proposed merger. The two companies were going to create a new business named The HighBrid Lab. The transaction was to be a reverse takeover of Red Light Holland by Creso Pharma giving Red Light shareholders a 29% premium for their shares. Creso shareholders would’ve owned 57% of the new company.  The new company was expected to have a cash balance of approximately C$45 million.

“We respect Todd Shapiro and the entire team at Red Light Holland. Unfortunately, the geographic span of our respective businesses made a merger at this time impractical,” added Creso Pharma’s Non-Executive Chairman, Adam Blumenthal. “We look forward to working with the Red Light Holland team through our new supply arrangement.”

 


Debra BorchardtJune 16, 2021
shutterstock_1517440529-scaled.jpg?fit=960%2C640&ssl=1

6min29290

Cannabis company Creso Pharma Limited  (ASX: CPH)  (OTCQB: COPHF) is merging with psychedelic treatment company Red Light Holland Corp. (CSE: TRIP) (OTC Pink: TRUFF) to create The HighBrid Lab. The transaction is a reverse takeover of Red Light Holland by Creso Pharma giving Red Light shareholders a 29% premium for their shares. Creso shareholders will own 57% of the new company.

The combined company will use the symbol TRIP. The new company is expected to have a cash balance of approximately C$45 million (A$48 million), providing considerable financial flexibility to progress its growth strategy.

Red Light Holland’s current Chief Executive Officer, Todd Shapiro, will lead HighBrid as CEO and Director.

“The company understands the sensitive complexities of the ingredients we deal with, while ensuring we continue to make a bold yet careful push to provide and increase access for immediate revenue generation and brand expansion. Our core principle is to compliantly lead with edgy consumer packaged goods focused on positive outcomes, while balancing a responsible, regulated, and educational use approach through technology and innovation,” said Todd Shapiro CEO and Director of Red Light Holland. “Merging with Creso Pharma, who also has significant cash on hand, and formulating The HighBrid Lab, with Bruce Linton as Chair of the Board, means we can expand our premium product offerings globally in the high growth CBD, THC and psychedelic sectors. Together we are bullish on developing world-class products with naturally occurring ingredients in clever and innovative ways for both humans and pets, which completely aligns with Creso Pharma’s R&D and sales approach. The HighBrid Lab ramps up our objectives for near and long-term growth targets, while potentially being a part of positive change. The HighBrid Lab is a perfect name combining psychedelics and cannabis coupled with recreational use, science, and technology. This is a monumental day for all of our shareholders and now their pets!”

Former Canopy Growth founder Bruce Linton is expected to join as Non-Executive Chairman of The HighBrid Lab’s board of directors. The board of directors will consist of seven members, three of which, including Mr. Shapiro, will be current directors of Red Light Holland, and three of which, will be directors or nominees of Creso Pharma.Mr. Bruce Linton is expected to be the seventh member, as non-executive Chairman. Mr. William Lay, previously Associate Director, M&A at Canopy Growth appointed Executive Vice President and Chief Strategy Officer to assist in growth trajectory.

“Having worked with both the Creso Pharma and Red Light Holland teams closely in the past, I am really excited by the potential this combination brings. As a merged company, The HighBrid Lab has access to four of the highest growth industry segments around, and the team, board and advisory group to make real progress within these verticals. I’m really looking forward to rolling up my sleeves and helping The HighBrid Lab get to work!” said Bruce Linton, who is expected to join the Combined Company’s board as non-executive Chairman.

Growth Objectives

HighBrid said its growth objectives include expanding market and brand leadership in recreational psilocybin. Applied science and innovation supporting long-term opportunities in psychedelics with both naturally occurring and pharmaceutical grade drug discovery aiming for advanced and approved product offerings through controlled lab environments via the pending acquisitions of Halucenex and Mera Life Sciences. Creso Pharma has conditionally agreed to acquire Canada-based psychedelics life sciences company, Halucenex, which has submitted an application for a Dealer’s License under both the Narcotics Control Regulations and Part J of the Food and Drugs Regulations. Red Light Holland recently extended its LOI with Mera Life Sciences and continues discussions regarding a previously announced potential investment in St. Vincent and the Grenadines, which is expected to be a part of the Combined Company’s applied science platform.

Despite the move towards psychedelics, the company said it will continue scaling its recreational cannabis offering in North America by focusing on increasing market share in Canada and taking advantage of its CSE listing to advance the introduction of products into the US.

In addition to separate paths for cannabis and mushrooms, the company said it plans on introducing recreational product offerings under existing Red Light Holland brands with applied science including combined CBD and mushroom products and ready to drink products with mushrooms, CBD and THC, while focusing on adding adjacent iMicrodose product lines with ingredients including CBD, THC and functional mushrooms, as and where permitted to do so. Already the market is seeing the introduction of CBD combinations with various legal mushroom products like Lions Mane, Reishi and Cordyceps.

 


StaffMarch 19, 2021
mushroom5.jpg?fit=960%2C523&ssl=1

3min25040

Ontario-based mushroom company Red Light Holland Corp. (OTC: TRUFF) announced that its wholly-owned subsidiary, RLH Netherlands B.V.  has completed the acquisition of SR Wholesale B.V., one of the Netherlands’ premiere distributors for quality psychedelic truffles. The company said in a statement that in 2020, SR Wholesale generated over $2.44 Million in revenues, and over $822,000 in gross profit, with approximately $400,000 of cash and working capital currently on hand.

The acquisition will give Red Light Holland access to many product offerings within the psychedelic sector including obtaining sole-ownership of the established Mister Maka Brand which produces Magic Truffles. It will also give Red Light Holland the instant opportunity to white-label to help with brand growth, exposure, and expansion.

“The acquisition of SR Wholesale marks the latest step in the company’s growth and expansion strategy, as we continue to move forward with a positive business outlook focused on achieving revenue growth, profitability, and value creation for our shareholders. We expect this transaction to serve as a launchpad for Red Light Holland to broaden operations, create new homes for our iMicrodose packs and build brand exposure into multiple European markets.” said Todd Shapiro, the Chief Executive Officer and Director of the Company. “We are quite thrilled, after months of tough negotiations and careful due diligence, to move forward as the largest legal psychedelic distribution publicly traded company in the world. As well, we are truly so pleased to work closely with Mr. Shai Ramsahai, who is one of the brightest, most determined and likeable entrepreneurs I’ve ever come across.”

“This is an exciting time for both SR Wholesale and Red Light Holland. After years of hard work we have established an incredible and profitable Distribution company with a huge network across the Netherlands and Europe. I believe that moving forward with Hans Derix (Red Light Holland’s President) and Todd Shapiro coupled with our extremely knowledgeable, loyal and committed team, that together we can grow our wholesale business to new heights,” said Shai Ramsahai, Founder of SR-Wholesale.

SR Wholesale also distributes popular CBD products, cannabis seeds, smart shop items, and headshop products, among others. SR Wholesale has established a distribution network of over 400 companies that sell their products across Europe, including working with sub-distributors that provide products to over 1,000 shops in countries like the Netherlands, Germany, Spain, Czech, Greece, UK, France, and Portugal.


Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 8 mins

MariMed Edges Up In Second Quarter Earnings

@GreenMarketRpt – 25 mins

Cronos Makes Gains In Second Quarter

@GreenMarketRpt – 1 hour

Cannabis Operators Plan To Raise Prices, Blaming Inflation

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.